PUBLISHER: Grand View Research | PRODUCT CODE: 1941427
PUBLISHER: Grand View Research | PRODUCT CODE: 1941427
The global medical writing market size was estimated at USD 5.07 billion in 2025 and is projected to reach USD 11.09 billion by 2033, growing at a CAGR of 10.29% from 2026 to 2033. The high demand for medical writers can be attributed to a rise in CRO outsourcing, increased R&D investments by market players, a favorable environment for clinical study in developing countries, and new medical device regulations.
In July 2024, Celegence highlighted in The Journal of mHealth that Generative AI (GenAI) could transform pharmaceutical medical writing, with 57% of organizations planning investment. While deployment knowledge is a challenge, controlled experiments and partnerships can boost efficiency, cut costs, and keep companies competitive. Pharmaceutical companies have adapted their advertising strategies to improve patient outreach. In addition, the growing influence of social media on customers' decisions has compelled pharmaceutical and biotechnology companies to reconsider their marketing strategies. The robust growth of health and wellness-related blogs is expected to boost the demand for scientific writing. In September 2025, an article published in Health Promotion International analyzed the scale of the medical writing industry, identifying 1,148 medical education and communication companies (MECCs) contributing to English-language medical literature. The study found that over 20,000 scientific papers acknowledged medical writing support, with more than 50% sponsored by just ten pharmaceutical companies, highlighting the industry's size and concentrated funding base.
Regulatory authorities want a thorough methodology for all phases of product development, which complicates the approval process boosting the market growth in the coming years. Insurance companies want drug information to establish reimbursement policies. As a result, pharmaceutical companies are finding it difficult to adhere to industry standards. In June 2024, an article published by the American Medical Writers Association (AMWA) Blog highlighted the expanding medical writing profession, citing U.S. Bureau of Labor Statistics projections of 7% growth in technical writing roles by 2032 and industry data showing nearly 8,000 medicines in development and about 900 FDA approvals since 2000, collectively pointing to sustained demand for medical writers across clinical, regulatory, and commercial activities.
There is a new trend in the market of multiple strategic relationships, wherein each CRO provides a single function and multiple service providers are maintained. Clinical trials are increasing in number as a result of increased R&D investments. In September 2024, the European Journal of Internal Medicine highlighted that AI and large language models are rapidly transforming scientific medical writing, aiding literature review, translation, and statistical analysis.
Global Medical Writing Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global medical writing market report based on type, application, end use, and region: